OGT, Oxford GKP Developing Oligo-Based Array CGH Tests for Bowel Cancer, Learning Disabilities | GenomeWeb

In a departure from its traditional role as a licensing company, Oxford Gene Technology has been working with Oxford Genetics Knowledge Park, a government-funded think tank, to bring array comparative genomic hybridization-based diagnostic tests to cytogenetics labs in the UK.

Initially, Oxford GKP will be using the technology to study colorectal cancer and learning disabilities, OGT said.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Familial DNA searches in criminal cases are winning over some critics, the Los Angeles Times reports.

In Nucleic Acids Research this week: ProTraits includes genetic, phenotypic data on bacteria, archaea; Candida albicans assembly 22; and more.

The Wall Street Journal reports that researchers are looking beyond Cas9 for CRISPR editing.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.